Advanced

Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.

Salehi, S Albert LU ; Meidute Abaraviciene, Sandra; Jimenez, Javier LU ; Ostenson, Claes-Göran; Efendic, Suad and Lundquist, Ingmar LU (2008) In PLoS One 3(5).
Abstract
BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor... (More)
BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. CONCLUSION: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
islet hormone secretion, ncNOS, Diabetic GK rat, iNOS, NOS inhibition, GLP-1
in
PLoS One
volume
3
issue
5
publisher
Public Library of Science
external identifiers
  • WOS:000262172800030
  • PMID:18478125
  • Scopus:47749085111
ISSN
1932-6203
DOI
10.1371/journal.pone.0002165
language
English
LU publication?
yes
id
002813cf-bc1f-49b1-9201-02e9fbebc4b2 (old id 1154188)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/18478125?dopt=Abstract
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002165
date added to LUP
2008-06-02 14:43:28
date last changed
2016-11-27 04:26:34
@misc{002813cf-bc1f-49b1-9201-02e9fbebc4b2,
  abstract     = {BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. CONCLUSION: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms.},
  author       = {Salehi, S Albert and Meidute Abaraviciene, Sandra and Jimenez, Javier and Ostenson, Claes-Göran and Efendic, Suad and Lundquist, Ingmar},
  issn         = {1932-6203},
  keyword      = {islet hormone secretion,ncNOS,Diabetic GK rat,iNOS,NOS inhibition,GLP-1},
  language     = {eng},
  number       = {5},
  publisher    = {ARRAY(0xb9d6e38)},
  series       = {PLoS One},
  title        = {Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.},
  url          = {http://dx.doi.org/10.1371/journal.pone.0002165},
  volume       = {3},
  year         = {2008},
}